Drugs and Devices

FDA approves drug for sexual desires disorders in women

On Aug. 18, the U.S. Food and Drug Administration (FDA) approved Addyi (flibanserin) to treat acquired, generalized hypoactive sexual desire disorder in premenopausal women. Read more


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares